23.10.2018 23:02:19

Edwards Lifesciences Corp. Q3 adjusted earnings Beat Estimates

(RTTNews) - Edwards Lifesciences Corp. (EW) released earnings for its third quarter that rose from last year.

The company's profit totaled $225.9 million, or $1.06 per share. This compares with $170.1 million, or $0.79 per share, in last year's third quarter.

Excluding items, Edwards Lifesciences Corp. reported adjusted earnings of $228.1 million or $1.07 per share for the period.

Analysts had expected the company to earn $1.02 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 10.4% to $906.6 million from $821.5 million last year.

Edwards Lifesciences Corp. earnings at a glance:

-Earnings (Q3): $228.1 Mln. vs. $181.8 Mln. last year. -EPS (Q3): $1.07 vs. $0.84 last year. -Analysts Estimate: $1.02 -Revenue (Q3): $906.6 Mln vs. $821.5 Mln last year.

-Guidance: Next quarter EPS guidance: $1.05 - $1.20 Next quarter revenue guidance: $0.95 - $1 Bln Full year EPS guidance: $4.60 - $4.75 Full year revenue guidance: $3.5 - $3.9 Bln

Analysen zu Edwards Lifesciences Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Edwards Lifesciences Corp. 71,90 1,05% Edwards Lifesciences Corp.